Biotech
Israeli life sciences investments fell 40% in 2025, report found
Investments in Israeli life sciences companies fell sharply in 2025, dropping 40% after a recovery the previous year, according to a report by the Israel Advanced Technology Industries Association.
Startup wants to grow “headless humans” to replace lab animals
Israeli mathematician uses AI to decode human immune system
Israel's overlooked challenge: Environmental damage from two years of war - from the editor
Immunai, Bristol Myers Squibb sign AI immune-data collaboration
The New York-based AI biotech will use its AMICA-OS platform to analyze clinical immune data for BMS, aiming to inform patient stratification, biomarkers, and trial decisions.
Israeli researchers develop SafeWax coating that could cut pesticide use by 50%
The team concluded that SafeWax is “an innovative technology with the potential to become a breakthrough in the field of sustainable crop protection.”
Arkin raises $100m for early-stage biotech fund
The main investors in Arkin Bio Ventures III together with Arkin Capital are Israeli institutional investors including Phoenix Finance, Clal Insurance, and Amitim pension fund
Israel's biotech moment: How science, data, and geopolitics are converging - opinion
Why now Is the time to invest in a deeply built, undervalued market
EU Council and Parliament reach agreement to overhaul drug rules, speed patient access
The agreement grants companies launching new medicines eight years of data protection for trial results and one year of market protection.
Midlife weight loss shows metabolic benefits but sparks brain inflammation in BGU - study
“Our findings show that losing weight in midlife is not a simple copy-and-paste of what works in young adulthood,” Alon Zemer said.
Biotech between worlds: Jacob Licht's aliyah story - interview
A better question might be: For a couple who fell in love with Israel as teenagers, why did it take us so long to make aliyah?
Israeli woman's vision restored in world's first-ever 3D-printed cornea implant
The new Israeli technology allows for the creation of hundreds of cornea implants from a single donor sample, offering a scalable solution.
Jerusalem surges ahead: Aspiring to become Israel’s biotech capital
Jerusalem's biotech sector grows with $1.7B in investments and 150 companies. In June, the city will host the international medical hackathon MinDstart.
Jerusalem as our biotech capital: The city’s ascent as an innovation hub - opinion
Jerusalem's transformation is the outcome of long-term strategic policy, targeted public investment, and a thriving academic ecosystem.